Skip to main content
. Author manuscript; available in PMC: 2010 Mar 23.
Published in final edited form as: Diabetes. 2007 Mar;56(3):836–848. doi: 10.2337/db06-1119

TABLE 1.

Clinical and laboratory characteristics

Lean Obese Type 2diabetes
n 8 8 12
Sex (male/female) 5/3 3/5 4/8
Age (years) 45 ± 3 44 ± 4 53 ± 3
BMI (kg/m2) 25.5 ± 1.0 30.5 ± 1.0* 31.5 ± 1.2*
Glucose (mmol/l) 5.3 ± 0.2 5.6 ± 0.1 7.7 ± 0.7*
A1C (%) 5.0 ± 0.1 4.9 ± 0.2 6.3 ± 0.3*
Insulin (pmol/l) 44 ± 3 126 ± 19* 85 ± 13*
FFA (μmol/l) 430 ± 40 510 ± 50 700 ± 40*
Insulin sensitivity index 6.5 ± 0.9 3.1 ± 0.5* 3.4 ± 0.8*
Adiponectin (μg/ml) 22.4 ± 3.0 15.4 ± 2.7* 14.8 ± 2.8*
Leptin (ng/ml) 8.6 ± 2.4 19.6 ± 3.0* 20.0 ± 3.2*
IL-6 (pg/ml) 1.2 ± 0.2 1.9 ± 0.5 2.4 ± 0.4*
VO2max (ml · kg−1 · min−1) 21.1 ± 2.3 20.8 ± 2.6 16.4 ± 0.4
Work
 Low intensity (W) 54 ± 5 53 ± 4 46 ± 2
 Moderate intensity (W) 79 ± 7 77 ± 6 67 ± 3

Data are mean ± SE.

*

P < 0.05 vs. lean;

P < 0.05 vs. obese.

HHS Vulnerability Disclosure